Page last updated: 2024-09-03

mci 154 and dpi 201-106

mci 154 has been researched along with dpi 201-106 in 1 studies

Compound Research Comparison

Studies (mci 154)	Trials (mci 154)	Recent Studies (post-2010) (mci 154)	Studies (dpi 201-106)	Trials (dpi 201-106)	Recent Studies (post-2010) (dpi 201-106)
65	1	0	104	4	4

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Tombe, P; Doye, A; Gwathmey, JK; Ito, T; Li, X; Liao, R; Okafor, C; Perreault-Micale, C; Stepanek, A	1

Other Studies

1 other study(ies) available for mci 154 and dpi 201-106

Article	Year
Mg-ATPase and Ca+ activated myosin AtPase activity in ventricular myofibrils from non-failing and diseased human hearts--effects of calcium sensitizing agents MCI-154, DPI 201-106, and caffeine. Molecular and cellular biochemistry, 2003, Volume: 245, Issue:1-2 Topics: Ca(2+) Mg(2+)-ATPase; Caffeine; Calcium; Cardiomyopathies; Cardiotonic Agents; Heart; Heart Ventricles; Humans; Myocardium; Myofibrils; Myosins; Piperazines; Pyridazines	2003

Article

Year

Mg-ATPase and Ca+ activated myosin AtPase activity in ventricular myofibrils from non-failing and diseased human hearts--effects of calcium sensitizing agents MCI-154, DPI 201-106, and caffeine.

Molecular and cellular biochemistry, 2003, Volume: 245, Issue:1-2

Topics: Ca(2+) Mg(2+)-ATPase; Caffeine; Calcium; Cardiomyopathies; Cardiotonic Agents; Heart; Heart Ventricles; Humans; Myocardium; Myofibrils; Myosins; Piperazines; Pyridazines

2003